Immune Markers Linked to Pregnancy Hypertension
What happened
New research indicates a link between maternal immune system dysregulation and hypertensive disorders of pregnancy (HDP). A retrospective cohort study found that certain immune markers derived from first-trimester blood counts are associated with the later development of HDP. This finding could lead to earlier identification of at-risk patients and guide preventive care.
Why it matters
- Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies globally and are a leading cause of maternal mortality. In the United States, the prevalence of HDP documented at delivery hospitalization increased from 13.3% in 2017 to 15.9% in 201
Key numbers
- - Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies globally and are a leading cause of maternal mortality.
- In the United States, the prevalence of HDP documented at delivery hospitalization increased from 13.3% in 2017 to 15.9% in 201
What happens next
- This finding could lead to earlier identification of at-risk patients and guide preventive care.
Quick answers
What happened in Immune Markers Linked to Pregnancy Hypertension?
New research indicates a link between maternal immune system dysregulation and hypertensive disorders of pregnancy (HDP). A retrospective cohort study found that certain immune markers derived from first-trimester blood counts are associated with the later development of HDP. This finding could lead to earlier identification of at-risk patients and guide preventive care.
Why does Immune Markers Linked to Pregnancy Hypertension matter?
Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies globally and are a leading cause of maternal mortality. In the United States, the prevalence of HDP documented at delivery hospitalization increased from 13.3% in 2017 to 15.9% in 201
